Earnings Call · Q4 FY2024·2025-02-26

Q4 24EPS -2.58%·Rev n/aQ3 24EPS +16.16%·Rev n/aQ2 24EPS -10.00%·Rev n/aQ1 24EPS +19.81%·Rev n/a⚠ consensus missing

Vaxcyte, Inc. PCVX

Andrew Guggenhime — Senior Vice President, Finance and Chief Financial Officer

Grant Pickering — Chief Executive Officer

Jim Wassil — Executive Vice President and Chief Operating Officer

−0.9%1d on move date−0.9% vs SPY3d−8.0%5d−11.5%

Research tier

Behavioral profile computed for 3 speakers on this call.

Sign in to view the Behavioral Lean, the Behavioral Deviation Score, the speaker decomposition, and the novel forward-guidance phrases flagged on this call — each scored against the speaker's own prior-call baseline.

Behavioral data on every earnings call

Per-speaker language deviation, scored against each executive's own history. Explore more PCVX calls or request research access.

More PCVX calls Browse calls Request research access